Results 201 to 210 of about 84,280 (274)

Amylin Coexisting With Peptide YY (PYY) and Amylin/PYY Cells Correspond to Subpopulations of Glucagon- and Glucagon-Like Peptide-1-Immunoreactive Cells in the Japanese Eel (Anguilla japonica) Pancreas. [PDF]

Anat Histol Embryol
Suzuki H, Yamamoto T.
europepmc   +1 more source

Correlation of ⁶⁸Ga-DOTATATE and ¹⁸F-FDG PET/CT Uptake Parameters with PASS and GAPP Scores in Pheochromocytoma. [PDF]

Diagnostics (Basel)
Ozturk Unsal I, Ucgul E, Unver CK, Dizdar N, Hepsen S, Calapkulu M, Erdem Karaoglu A, Cayir D, Cakal E.   +8 more
europepmc   +1 more source

Free fatty acid receptor 4 agonism stimulates insulin secretion via different mechanisms in mouse versus human islets.

Endocrinology
Reininger L, Rehman M, Hart R, Ferragne S, Tremblay C, Ethier M, Bouabcha A, Kimple M, Ghislain J, Huising MO, Poitout V.   +10 more
europepmc   +1 more source

A silent tumor, a loud valve: carcinoid heart disease as the first manifestation of a pelvic neuroendocrine tumor. [PDF]

JCEM Case Rep
Dutta P, Gupta N, Bhadada SK, Jha V, Soundararajan R, Gulati A.   +5 more
europepmc   +1 more source

Pregnancy in a patient with metastatic functioning midgut neuroendocrine tumor receiving lanreotide after peptide receptor radionuclide therapy. [PDF]

Arch Endocrinol Metab
Silva BTD, Maia A, Pereira MT, Santos S, Garrido S, Vilaverde J, Moreira MS, Pinto C, Santos AP, Dores J.   +9 more
europepmc   +1 more source

Decoding Brain Development and Function Through GABAergic Inhibitory Neurons. [PDF]

Eur J Neurosci
Batista-Brito R, Mayer C, Paredes M, Silva CG.   +3 more
europepmc   +1 more source

A Novel Index Consisting of Age, CA19-9, and Methylated Somatostatin Is Useful for Diagnosing Early Pancreatic Cancer. [PDF]

Cancer Med
Tabara S, Suehiro Y, Suehiro H, Shinagawa U, Hamamoto K, Tsuyama T, Shinoda S, Suenaga S, Kunimune Y, Fujii I, Suzuki C, Higaki S, Takami T, Yamasaki T.   +13 more
europepmc   +1 more source

Somatostatin and the Gut

Gastroenterology, 1978
openaire   +2 more sources

Reduced breakthrough symptom exacerbations in patients with biochemically controlled acromegaly switched from injected depot somatostatin receptor ligands to once-daily oral paltusotine in the PATHFNDR-1 clinical trial. [PDF]

Pituitary
Clemmons DR, Quock TP, Casagrande A, Wang Y, Krasner A.   +4 more
europepmc   +1 more source

Future scenarios of radioligand therapy in pheochromocytomas and paragangliomas. [PDF]

EJNMMI Rep
Pacella S, Elisei F, Mattoli MV, Airò Farulla LS, Aliberti G, Rizzo A, Maccauro M.   +6 more
europepmc   +1 more source